U.S. Hemophilia Treatment Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2024 - 2031)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market Leaders

  • Takeda pharmaceutique Société limitée
  • Sanofi Octapharma AG
  • orphelin suédois Biovitrum AB
  • Baxter International Autres
  • Biogen Inc.
*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

  • Takeda pharmaceutique Société limitée
  • Sanofi Octapharma AG
  • orphelin suédois Biovitrum AB
  • Baxter International Autres
  • Biogen Inc.
  • Bayer AG
  • CSL Bière
  • Ferry B.V.
  • La société Pfizer, Inc.
  • Kédiron
  • Novo Nordisk A/S
  • Griffols S.A.
  • Sangamo Therapeutics, Inc.
  • Spark Therapeutics, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now